Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yellow fever vaccine, live
- Development stage
- Unknown
- Lead developer
- Beijing Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Yellow fever vaccine, live is a live attenuated vaccine derived from the 17D strain of the yellow fever virus, grown in specific pathogen-free (SPF) chicken embryos. Developed by the Beijing Institute of Biological Products, it is used to induce active, long-lasting protective immunity against yellow fever in individuals traveling to or living in endemic regions. The vaccine is formulated as a lyophilized powder for reconstitution and is administered subcutaneously as a single dose.
- Other names
- 17D yellow fever vaccineLive attenuated yellow fever vaccineYellow Fever Vaccine (Live)黄热减毒活疫苗
Beyond the preview
Go deeper on yellow fever vaccine, live.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yellow fever vaccine, live.